Yan X, Qiao J. Emerging treatment options for meibomian gland dysfunction. Clin Ophthalmol. 2013;7:1797–803. Maskin SL, Alluri S. Meibography guided intraductal meibomian gland probing using real-time infrared video feed. Br J Ophthalmol. 2020 VTP increased TBUT and the number of functional MGs as well as reduced ocular symptoms for up to 3months Zhao Y, Xie J, Li J, et al. Evaluation of monocular treatment for meibomian gland dysfunction with an automated thermodynamic system in elderly chinese patients: a contralateral eye study. J Ophthalmol. 2016;27:1–8.

The EyeBag can be used as a treatment for sore gritty eyes, dry eye syndrome, Meibomian Gland Dysfunction, Chalazion treatment, Stye treatment and Blepharitis treatment. Two studies (III) suggested that Blephasteam ® might be a safe and effective therapy for MGD because DED symptoms and MG function improved after 21 days of treatment [ 30, 31]. Ocular symptoms and clinical signs, except the conjunctival redness score, may achieve a higher improvement after Blephasteam ® than after warm compresses (III) [ 32]. However, in another study (I), signs improved equally in both therapies [ 33]. Nonetheless, Blephasteam ® may be useful for subjects who find warm compresses ineffective (III) [ 34]. Warming and Massaging Devices Finis D, Hayajneh J, König C, Borrelli M, Schrader S, Geerling G. Evaluation of an automated thermodynamic treatment (Lipiflow ®) system for meibomian gland dysfunction: a prospective, randomized, observer-masked trial. Ocul Surf. 2014;12(2):146–54.BEFORE FIRST USE, HEAT YOUR BLEPHA EYEBAG® FOR 1 MINUTE ON FULL POWER AND LEAVE TO COOL COMPLETELY. Geerling G, Tauber J, Baudouin C, et al. The international workshop on meibomian gland dysfunction: report of the subcommittee on management and treatment of meibomian gland dysfunction. Investig Opthalmol Vis Sci. 2011;52(4):2050. Villani E, Garoli E, Canton V, Pichi F, Nucci P, Ratiglia R. Evaluation of a novel eyelid-warming device in meibomian gland dysfunction unresponsive to traditional warm compress treatment: an in vivo confocal study. Int Ophthalmol. 2015;35(3):319–23.

The TearCare ® System (Sight Sciences, USA) is an electrothermal controller that heats both eyelids to 41–45 °C by adjusting them with a flexible, single-use material called iLid™. The system encourages meibum expression through normal blinking during the treatment and through the subsequent manual MG expression—the set includes a disposable EXPRESS™ Forceps to perform the manoeuvre. Badawi et al. [ 22, 23] performed a clinical trial (I) evaluating the effectiveness of the TearCare ® System and the MGDRx EyeBag ® in two different groups of MGD patients. While one group underwent the TearCare ® for 12 min and subsequent MG expression, the other group self-applied 5 min of daily therapy with EyeBag ® for 4 weeks. The TearCare ® group showed a higher improvement in signs, including MG scores, and symptoms. Additionally, the effects lasted for 6 months, and no adverse events were reported. Probing improved subjective symptoms, meibum grade, TBUT, lid margin abnormalities, and fluorescein staining compared with the control STEP 5: Remove Blepha EyeBag® from your eyes. It is normal to observe skin redness after use due to the warming effect of the mask. This study aims to evaluate the relationship between application of the MGDRx thermal eyebag and dry eye signs and symptoms in young and older subjects and to compare the results between the two groups. Epstein IJ, Rosenberg E, Stuber R, Choi MB, Donnenfeld ED, Perry HD. Double-masked and unmasked prospective study of terpinen-4-ol lid scrubs with microblepharoexfoliation for the treatment of demodex blepharitis. Cornea. 2020;39(4):408–16.

Comments (0)

Finis D, König C, Hayajneh J, Borrelli M, Schrader S, Geerling G. Six-month effects of a thermodynamic treatment for MGD and implications of meibomian gland atrophy. Cornea. 2014;33(12):1265–70.